Kristopher J Kimball, MD | |
1934 Alcoa Hwy, Ste 478, Knoxville, TN 37920-1524 | |
(865) 305-5622 | |
(865) 305-4580 |
Full Name | Kristopher J Kimball |
---|---|
Gender | Male |
Speciality | Gynecological Oncology |
Experience | 21 Years |
Location | 1934 Alcoa Hwy, Knoxville, Tennessee |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073721635 | NPI | - | NPPES |
1518855 | Medicaid | TN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207VX0201X | Obstetrics & Gynecology - Gynecologic Oncology | 45968 (Tennessee) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
University Of Tn Medical Center | Knoxville, TN | Hospital |
Cumberland Medical Center | Crossville, TN | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Health System, Inc. | 5294646378 | 526 |
News Archive
Echo Therapeutics, Inc., a company developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude® SkinPrep System for transdermal drug delivery, today announced that it is initiating a clinical study of its Symphony tCGM System in patients with Type 1 and Type 2 diabetes.
"A former Massachusetts dentist accused of Medicaid fraud for using paper clips instead of stainless steel posts in patients' root canals has pleaded not guilty to the charges against him." The dentist, Michael Clair, was released on personal recognizance.
Politico reports that "inside the talks," a framework for addressing the "fiscal cliff" is taking shape that includes both tax increases and entitlement cuts. Other news outlets note that publicly, President Barack Obama is playing down spending cuts, while GOP leaders demand entitlement reductions but offer few specifics.
Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) today announced that it has submitted an application for Orphan Drug Designation to the U.S. Food and Drug Administration ("FDA") for REOLYSIN® for the treatment of high grade gliomas (HGG) in pediatric patients.
› Verified 9 days ago
Entity Name | University Health System, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1790738763 PECOS PAC ID: 5294646378 Enrollment ID: O20031111000809 |
News Archive
Echo Therapeutics, Inc., a company developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude® SkinPrep System for transdermal drug delivery, today announced that it is initiating a clinical study of its Symphony tCGM System in patients with Type 1 and Type 2 diabetes.
"A former Massachusetts dentist accused of Medicaid fraud for using paper clips instead of stainless steel posts in patients' root canals has pleaded not guilty to the charges against him." The dentist, Michael Clair, was released on personal recognizance.
Politico reports that "inside the talks," a framework for addressing the "fiscal cliff" is taking shape that includes both tax increases and entitlement cuts. Other news outlets note that publicly, President Barack Obama is playing down spending cuts, while GOP leaders demand entitlement reductions but offer few specifics.
Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) today announced that it has submitted an application for Orphan Drug Designation to the U.S. Food and Drug Administration ("FDA") for REOLYSIN® for the treatment of high grade gliomas (HGG) in pediatric patients.
› Verified 9 days ago
Entity Name | University Of Tennessee |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1295751386 PECOS PAC ID: 3072421213 Enrollment ID: O20040110000145 |
News Archive
Echo Therapeutics, Inc., a company developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude® SkinPrep System for transdermal drug delivery, today announced that it is initiating a clinical study of its Symphony tCGM System in patients with Type 1 and Type 2 diabetes.
"A former Massachusetts dentist accused of Medicaid fraud for using paper clips instead of stainless steel posts in patients' root canals has pleaded not guilty to the charges against him." The dentist, Michael Clair, was released on personal recognizance.
Politico reports that "inside the talks," a framework for addressing the "fiscal cliff" is taking shape that includes both tax increases and entitlement cuts. Other news outlets note that publicly, President Barack Obama is playing down spending cuts, while GOP leaders demand entitlement reductions but offer few specifics.
Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) today announced that it has submitted an application for Orphan Drug Designation to the U.S. Food and Drug Administration ("FDA") for REOLYSIN® for the treatment of high grade gliomas (HGG) in pediatric patients.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Kristopher J Kimball, MD Po Box 440459, Nashville, TN 37244-0459 Ph: (865) 670-6199 | Kristopher J Kimball, MD 1934 Alcoa Hwy, Ste 478, Knoxville, TN 37920-1524 Ph: (865) 305-5622 |
News Archive
Echo Therapeutics, Inc., a company developing the Symphony tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and the Prelude® SkinPrep System for transdermal drug delivery, today announced that it is initiating a clinical study of its Symphony tCGM System in patients with Type 1 and Type 2 diabetes.
"A former Massachusetts dentist accused of Medicaid fraud for using paper clips instead of stainless steel posts in patients' root canals has pleaded not guilty to the charges against him." The dentist, Michael Clair, was released on personal recognizance.
Politico reports that "inside the talks," a framework for addressing the "fiscal cliff" is taking shape that includes both tax increases and entitlement cuts. Other news outlets note that publicly, President Barack Obama is playing down spending cuts, while GOP leaders demand entitlement reductions but offer few specifics.
Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ: ONCY) today announced that it has submitted an application for Orphan Drug Designation to the U.S. Food and Drug Administration ("FDA") for REOLYSIN® for the treatment of high grade gliomas (HGG) in pediatric patients.
› Verified 9 days ago
Dr. Periclis Roussis, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 501 19th St., Suite 401, Knoxville, TN 37916 Phone: 865-331-2020 Fax: 865-331-2019 | |
Dr. George Walton Smith, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 501 19th St., Suite 401, Knoxville, TN 37916 Phone: 865-541-1975 Fax: 865-541-1976 | |
Dr. Roy Cox Broady, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 501 19th Street, Suite 509, Knoxville, TN 37916 Phone: 865-524-3208 Fax: 865-522-4322 | |
Courtney Roth, NP Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1926 Alcoa Hwy Ste 370, Knoxville, TN 37920 Phone: 865-305-5622 | |
Dr. Lynlee Marie Wolfe, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1925 Alcoa Hwy, Suite 6-south, Knoxville, TN 37920 Phone: 865-305-8888 | |
Jeffrey A Keenan, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 11126 Kingston Pike, Knoxville, TN 37934 Phone: 865-777-0088 Fax: 865-777-2015 |